Home Cart 0 Sign in  
X

[ CAS No. 2971-79-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 2971-79-1
Chemical Structure| 2971-79-1
Chemical Structure| 2971-79-1
Structure of 2971-79-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2971-79-1 ]

Related Doc. of [ 2971-79-1 ]

Alternatived Products of [ 2971-79-1 ]

Product Details of [ 2971-79-1 ]

CAS No. :2971-79-1 MDL No. :MFCD00190578
Formula : C7H13NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 143.18 Pubchem ID :-
Synonyms :

Calculated chemistry of [ 2971-79-1 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.86
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 41.65
TPSA : 38.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.49 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.93
Log Po/w (XLOGP3) : -0.44
Log Po/w (WLOGP) : -0.22
Log Po/w (MLOGP) : 0.35
Log Po/w (SILICOS-IT) : 0.9
Consensus Log Po/w : 0.5

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.32
Solubility : 68.8 mg/ml ; 0.48 mol/l
Class : Very soluble
Log S (Ali) : 0.1
Solubility : 180.0 mg/ml ; 1.26 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -1.14
Solubility : 10.3 mg/ml ; 0.0723 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.19

Safety of [ 2971-79-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P210-P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P370+P378-P403+P233-P403+P235-P405-P501 UN#:N/A
Hazard Statements:H227-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2971-79-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2971-79-1 ]
  • Downstream synthetic route of [ 2971-79-1 ]

[ 2971-79-1 ] Synthesis Path-Upstream   1~23

  • 1
  • [ 2971-79-1 ]
  • [ 6457-49-4 ]
Reference: [1] European Journal of Organic Chemistry, 2008, # 25, p. 4277 - 4295
  • 2
  • [ 2971-79-1 ]
  • [ 39546-32-2 ]
Reference: [1] Patent: WO2016/65582, 2016, A1, . Location in patent: Page/Page column 49
  • 3
  • [ 1262670-73-4 ]
  • [ 2971-79-1 ]
YieldReaction ConditionsOperation in experiment
89% With ammonium cerium (IV) nitrate; water; acetic acid In dichloromethane at 20℃; for 1 h; Inert atmosphere The substrate (1 equiv) was added to a solution of CAN (20 mol percent) in minimum amount of water (roughly 15 equiv). The reaction mixture was dissolved in dichloromethane and stirred magnetically. Acetic acid (10 equiv) was added to the solution and left to stir at rt for the required time mentioned in Table 2. Upon completion of the reaction, the solvent was evaporated under reduced pressure and worked up in the following methods. Method A: The solid residue was washed twice with petroleum ether to remove the by product trityl alcohol. The residue was then dissolved in methanol and filtered through a short pad of celite. Removal of the solvent under reduced pressure yielded the free amine. Method B: Water and acetic acid were removed from the reaction mixture in vacuo. The residue was dissolved in dry dichloromethane, followed by the addition of triethylamine (2.5 equiv) and acetic anhydride or benzoyl chloride (1.5 equiv). After the completion of the reaction, the solvent was evaporated. The residue was extracted with ethyl acetate twice. The combined organic layer was washed with water and brine and finally dried (Na2SO4). Solvent was removed under reduced pressure and the residue obtained was purified by silica gel column chromatography to afford the acylated amine.
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 1, p. 34 - 37
  • 4
  • [ 2459-09-8 ]
  • [ 2971-79-1 ]
Reference: [1] European Journal of Organic Chemistry, 2009, # 9, p. 1327 - 1334
[2] Journal of Organic Chemistry, 1955, vol. 20, p. 1761,1765
  • 5
  • [ 67-56-1 ]
  • [ 498-94-2 ]
  • [ 2971-79-1 ]
Reference: [1] Journal of the American Chemical Society, 2001, vol. 123, # 27, p. 6496 - 6502
[2] Journal of the American Chemical Society, 2000, vol. 122, # 45, p. 11270 - 11271
[3] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 18, p. 2693 - 2698
[4] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3674 - 3680
[5] Tetrahedron, 2008, vol. 64, # 28, p. 6635 - 6644
[6] European Journal of Medicinal Chemistry, 2010, vol. 45, # 7, p. 2827 - 2840
[7] Patent: WO2014/150132, 2014, A1, . Location in patent: Page/Page column 44
[8] Patent: WO2016/8064, 2016, A1, . Location in patent: Page/Page column 39
[9] Patent: WO2016/10801, 2016, A1, . Location in patent: Page/Page column 33
[10] Patent: WO2016/65582, 2016, A1, . Location in patent: Page/Page column 49
[11] Patent: WO2016/122994, 2016, A1, . Location in patent: Page/Page column 42
  • 6
  • [ 498-94-2 ]
  • [ 2971-79-1 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1932, vol. 4, p. 259,263
[2] Helvetica Chimica Acta, 1954, vol. 37, p. 1672,1676
[3] Tetrahedron, 1995, vol. 51, # 30, p. 8355 - 8362
[4] Patent: WO2004/104001, 2004, A2, . Location in patent: Page 59
  • 7
  • [ 1083159-12-9 ]
  • [ 2971-79-1 ]
Reference: [1] Organic Letters, 2008, vol. 10, # 22, p. 5155 - 5158
  • 8
  • [ 67-56-1 ]
  • [ 84358-13-4 ]
  • [ 2971-79-1 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 12, p. 2663 - 2665
  • 9
  • [ 55-22-1 ]
  • [ 2971-79-1 ]
Reference: [1] Helvetica Chimica Acta, 1954, vol. 37, p. 1672,1676
  • 10
  • [ 128094-80-4 ]
  • [ 2971-79-1 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1932, vol. 4, p. 259,263
  • 11
  • [ 857778-39-3 ]
  • [ 2971-79-1 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1932, vol. 4, p. 259,263
  • 12
  • [ 67-56-1 ]
  • [ 2971-79-1 ]
  • [ 1690-75-1 ]
YieldReaction ConditionsOperation in experiment
91% With formaldehyd; formic acid In water for 3 h; Heating / reflux To a stirred solution of methyl isonipecotate (L. OOG, 7.00 mmol) in methanol (25 ml) was added formic acid (5.52g, 12.00 mmol) and a solution of formaldehyde (2.67g, 35.00 mmol, 40percent aqueous) and the reaction heated at reflux. After 3 hours the reaction was cooled and concentrated under reduced pressure. The aqueous solution was basified with NAHC03 and extracted with DCM (3 x 30 ml), dried (MGSO4) and concentrated under reduced pressure to give a brown liquid (L. OOG, 910-.) ; b (270 MHz; CDC13 ; Me4Si), 1.69-2. 03 (6 H, m), 2.23-2. 32 (4H, m), 2.78- 2.83 (2H, m), 3.68 (3 H, s); M/Z (APCI) 158 (100percent [M+H] +), 126 (33, C7H120N).
Reference: [1] Patent: WO2004/58259, 2004, A1, . Location in patent: Page/Page column 26-27
  • 13
  • [ 2971-79-1 ]
  • [ 1690-75-1 ]
Reference: [1] Patent: US5380731, 1995, A,
  • 14
  • [ 2971-79-1 ]
  • [ 50-00-0 ]
  • [ 1690-75-1 ]
Reference: [1] Journal of Organic Chemistry, 1955, vol. 20, p. 1761,1765
[2] Archiwum Chemji i Farmacji, 1936, vol. 3, p. 109,113[3] Chem. Zentralbl., 1937, vol. 108, # II, p. 74
  • 15
  • [ 2971-79-1 ]
  • [ 100-39-0 ]
  • [ 10315-06-7 ]
YieldReaction ConditionsOperation in experiment
88% With triethylamine In chloroform at 20℃; To A solution of METHYL PIPERIDINE-4-CARBOXYLATE (10. 00 G, 6. 4 MMOL) AND triethylamine (10. 32 G, 10. 2 MMOL) IN CHC13 (100 ML), BENZYL BROMIDE (14. 69 G, 8. 6 mmol) was added under argon atmosphere while cooling with a water and ice bath. The mixture was stirred at room temperature overnight. CHCI3 and water were added and the two phases were separated. The aqueous phase was extracted with CHCI3. The organic phase was dried over NA2S04 and concentrated to dryness, to afford 13. 80 G OF THE DESIRED COMPOUND AS AN ORANGE solid (YIELD : 88percent)
78% With potassium carbonate In acetonitrile at 85℃; Inert atmosphere General procedure: A mix of methyl piperidine-4-carboxylate or ethyl 2-(piperidin-4-yl)acetate (10 mmol) in acetonitrile (20 ml), 1a–j (11 mmol),anhydrous K2CO3 (12 mmol) was refluxed under nitrogen for 8 hat 85 C. The mixture was then cooled and filtered and the solvent removed in vacuum. The residue was dissolved in ethyl acetate(50 ml) and washed with water (15 ml). Drying and removal of the solvent followed by chromatography (ethyl acetate/petroleumether = 1:4) afforded desired product 2a–j.
Reference: [1] Arkivoc, 2010, vol. 2010, # 10, p. 132 - 148
[2] Patent: WO2004/76450, 2004, A1, . Location in patent: Page 43-44
[3] Synthesis, 2002, # 7, p. 911 - 915
[4] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 18, p. 4324 - 4338
  • 16
  • [ 2971-79-1 ]
  • [ 100-44-7 ]
  • [ 10315-06-7 ]
YieldReaction ConditionsOperation in experiment
98.6% With triethylamine In 1,2-dichloro-ethane at 10 - 20℃; for 1.5 h; Reflux; Large scale In the 1000L reactor, 360 kg of 1,2-dichloroethane was recovered in Example 2, and 69.54 kg of new 1,2-dichloroethane was added.Under stirring, 143.18 kg of methyl piperidinecarboxylate and 121.43 kg of triethylamine were added, and benzyl chloride 139.24 kg was added dropwise at a temperature of 10 to 20°C.After the dripping is completed, the temperature is gradually raised to reflux for 1.5 hours. The reaction of the raw material is completely cooled to 20 to 30° C., and 150 kg of water is added for 30 minutes to separate the liquid.The organic layer was dried, filtered, and the filtrate was concentrated to obtain 230.04 kg of methyl N-benzyl-4-piperidinecarboxylate;The molar yield was 98.6percent and the purity was 99.61percent.The 1,2-dichloroethane was recovered for the next reaction.
Reference: [1] Patent: CN107903206, 2018, A, . Location in patent: Paragraph 0022; 0023; 0024; 0025
[2] Patent: WO2008/31227, 2008, A1, . Location in patent: Page/Page column 37
[3] ChemSusChem, 2016, vol. 9, # 1, p. 67 - 74
  • 17
  • [ 2971-79-1 ]
  • [ 10315-07-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 18, p. 4324 - 4338
  • 18
  • [ 2971-79-1 ]
  • [ 24424-99-5 ]
  • [ 124443-68-1 ]
YieldReaction ConditionsOperation in experiment
98% With triethylamine In dichloromethane at 25℃; for 12 h; Synthesis of 9-(Azetidin-1-yl)-9-phenyl-3-azaspiro[5.5]undecane Trifluoroacetate (A4); Step-1: 1-tert-Butyl 4-methyl piperidine-1,4-dicarboxylate; To a stirred solution of methyl isonipecotate (127.2 mmol, 1 eq) in dichloromethane (200 ml) were added di-tert-butyldicarbonate (190.8 mmol, 1.5 eq) and triethylamine (254.4 mmol, 2.0 eq). The reaction mixture was stirred for 12 h at 25° C. It was then diluted with dichloromethane (100 ml) and washed with water (50 ml) and brine (50 ml). The organic layer was separated, dried over Na2SO4, concentrated and employed in the next step without further purification. Yield: 98percent
95.5% With triethylamine In dichloromethane at 20℃; for 8 h; The 1L round-bottom flask is added in piperidine-4-carboxylic acid methyl ester (30g, 0.21mol), dissolved in 500 ml of in DCM, constant voltage dropping funnel for dropping (Boc)2O (45.72g, 0 . 21mol), triethylamine (42.3g, 0 . 42mol), stirring the mixture at room temperature for, 8 hours after the completion of the reaction, the volume of water to wash DCM layer 3 times, and evaporation drying of colorless oily organic 97.5g, yield 95.5percent.
86% With triethylamine In dichloromethane at 20℃; for 1 h; A. Synthesis of l-fert-butyl-4-methyl piperidine-l,4-dicarboxylate; [0065] Methyl isonipecotate (5 mL, 33 mmol), di-tert-butyl-dicarbonate (7 g, 33 mmol) and TEA (6.3 mL, 49.5 mmol) were stirred in DCM (100 mL) under N2 at rt for 1 h. The reaction was diluted to twice its volume with DCM, washed twice with saturated sodium bicarbonate solution followed by one wash with H2O. The organic layer was separated, dried over MgSO4 and concentrated to yield crude product (6.9 g, 86percent) as a clear colorless oil that was sufficiently pure to use in subsequent reactions.
75% With triethylamine In dichloromethane at 20℃; for 16 h; To a solution of methyl piperidine-4-carboxylate (3.0 g, 21.0 mmol, 1.0 eq) in CH2C12 (70 mL) were added Et3N (3.18 g, 31.5 mmol, 1.5 eq) and (Boc)20 (5.04 g, 23.1 mmol, 1.1 eq). Then the reaction mixture was stirred at room temperature for 16 h. After concentration, the residue was purified by silica gel column (PE: EA = 3:1) to give 1-tert- butyl 4-methyl piperidine-l,4-dicarboxylate as colorless gum (3.8 g, Y: 75percent). ESTMS (M+H) +: 244.1. 1H NMR (400 MHz, CDC13) δ: 4.03-4.00 (m, 2H), 3.67 (s, 3H), 2.86- 2.79 (m, 2H), 2.48-2.42 (m, 1H), 1.89-1.85 (m, 2H), 1.67-1.57 (m, 2H), 1.45 (s, 9H).

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 18, p. 5036 - 5040
[2] Patent: US2010/113417, 2010, A1, . Location in patent: Page/Page column 36
[3] Patent: CN105541798, 2016, A, . Location in patent: Paragraph 0120; 0121
[4] Patent: WO2008/31227, 2008, A1, . Location in patent: Page/Page column 21
[5] Patent: WO2012/109108, 2012, A1, . Location in patent: Page/Page column 121
[6] Patent: WO2007/71035, 2007, A1, . Location in patent: Page/Page column 36-37
[7] Patent: WO2009/61676, 2009, A2, . Location in patent: Page/Page column 70-71
[8] European Journal of Medicinal Chemistry, 2010, vol. 45, # 7, p. 2827 - 2840
[9] Patent: US2006/63775, 2006, A1, . Location in patent: Page/Page column 18
[10] European Journal of Medicinal Chemistry, 2011, vol. 46, # 7, p. 3085 - 3092
[11] Patent: WO2014/150132, 2014, A1, . Location in patent: Page/Page column 44
[12] Patent: WO2016/8064, 2016, A1, . Location in patent: Page/Page column 39
[13] Patent: WO2016/10801, 2016, A1, . Location in patent: Page/Page column 33
[14] Patent: WO2016/122994, 2016, A1, . Location in patent: Page/Page column 42
  • 19
  • [ 2971-79-1 ]
  • [ 91419-52-2 ]
Reference: [1] Patent: WO2016/65582, 2016, A1,
  • 20
  • [ 2971-79-1 ]
  • [ 501-53-1 ]
  • [ 138163-07-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 8, p. 2354 - 2359
[2] Patent: US2007/129345, 2007, A1, . Location in patent: Page/Page column 18
[3] Patent: US2016/52883, 2016, A1, . Location in patent: Paragraph 0085; 0123
  • 21
  • [ 2971-79-1 ]
  • [ 187834-88-4 ]
Reference: [1] European Journal of Medicinal Chemistry, 2011, vol. 46, # 7, p. 3085 - 3092
  • 22
  • [ 2971-79-1 ]
  • [ 268550-48-7 ]
Reference: [1] Patent: WO2014/150132, 2014, A1,
[2] Patent: WO2016/8064, 2016, A1,
[3] Patent: WO2016/10801, 2016, A1,
[4] Patent: WO2016/122994, 2016, A1,
  • 23
  • [ 2971-79-1 ]
  • [ 32779-36-5 ]
  • [ 914347-01-6 ]
YieldReaction ConditionsOperation in experiment
41% With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 16 h; Step 1 : DIPEA (4 mL, 23.20 mmol) was added to 5-bromo-2-chloropyrimidine (3.0 g, 15.50 mmol) in acetonitrile (80 mL). Then, methyl isonipecotate (3.321 g, 23.20 mmol) was added to the solution. The reaction mixture was stirred at rt for Ex.9a 16h. The solvent was concentrated to dryness. Water and EtOAc were added to quench the reaction. The organic layer was separated and concentrated to dryness. The crude material was purified by silica gel column chromatography eluting with heptane and a gradient of heptane/EtOAc from [100:0] to [0:100]. The product fractions were combined and concentrated to dryness to afford methyl 1-(5-bromopyrimidin-2-yl)piperidine-4-carboxylate Ex.9a (1 .84 mg, 41 percent) as white solid.
Reference: [1] Patent: WO2018/138356, 2018, A1, . Location in patent: Page/Page column 35; 40-41
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2971-79-1 ]

Esters

Chemical Structure| 7462-86-4

[ 7462-86-4 ]

Methyl piperidine-4-carboxylate hydrochloride

Similarity: 0.97

Chemical Structure| 1126-09-6

[ 1126-09-6 ]

Ethyl piperidine-4-carboxylate

Similarity: 0.95

Chemical Structure| 1690-75-1

[ 1690-75-1 ]

Methyl 1-methylpiperidine-4-carboxylate

Similarity: 0.95

Chemical Structure| 50585-89-2

[ 50585-89-2 ]

Methyl piperidine-3-carboxylate

Similarity: 0.92

Chemical Structure| 147636-76-8

[ 147636-76-8 ]

Ethyl piperidine-4-carboxylate hydrochloride

Similarity: 0.92

Related Parent Nucleus of
[ 2971-79-1 ]

Aliphatic Heterocycles

Chemical Structure| 7462-86-4

[ 7462-86-4 ]

Methyl piperidine-4-carboxylate hydrochloride

Similarity: 0.97

Chemical Structure| 1126-09-6

[ 1126-09-6 ]

Ethyl piperidine-4-carboxylate

Similarity: 0.95

Chemical Structure| 50585-89-2

[ 50585-89-2 ]

Methyl piperidine-3-carboxylate

Similarity: 0.92

Chemical Structure| 147636-76-8

[ 147636-76-8 ]

Ethyl piperidine-4-carboxylate hydrochloride

Similarity: 0.92

Chemical Structure| 81270-37-3

[ 81270-37-3 ]

Methyl 2-(piperidin-4-yl)acetate hydrochloride

Similarity: 0.92

Piperidines

Chemical Structure| 7462-86-4

[ 7462-86-4 ]

Methyl piperidine-4-carboxylate hydrochloride

Similarity: 0.97

Chemical Structure| 1126-09-6

[ 1126-09-6 ]

Ethyl piperidine-4-carboxylate

Similarity: 0.95

Chemical Structure| 1690-75-1

[ 1690-75-1 ]

Methyl 1-methylpiperidine-4-carboxylate

Similarity: 0.95

Chemical Structure| 50585-89-2

[ 50585-89-2 ]

Methyl piperidine-3-carboxylate

Similarity: 0.92

Chemical Structure| 147636-76-8

[ 147636-76-8 ]

Ethyl piperidine-4-carboxylate hydrochloride

Similarity: 0.92